[Federal Register Volume 74, Number 30 (Tuesday, February 17, 2009)]
[Notices]
[Page 7452]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-3211]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Molecular Pharmacodynamic Assays for Targeted 
Therapies.
    Date: March 19, 2009.
    Time: 10:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Conference Room 611, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Jeannette F. Korczak, PhD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8115, Bethesda, MD 20892, 301-496-9767, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Affinity Capture Tools and Technology.
    Date: March 25, 2009.
    Time: 12:01 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8018, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Caron Lyman, PhD, Scientific Review Officer, 
Division of Extramural Activities, Research Programs Review Branch, 
National Cancer Institute, NIH, 6116 Executive Blvd., Room 8119, 
Bethesda, MD 20892-8328, 301-451-4761, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Multifunctional Therapeutics Based on Nanotechnology.
    Date: April 6-7, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: M Street Renaissance Hotel-Marriott, 1143 New Hampshire 
Avenue, NW., Washington, DC 20037.
    Contact Person: Irina V. Gordienko, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7073, Bethesda, MD 20892-8329, 301-594-1566, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-3211 Filed 2-13-09; 8:45 am]
BILLING CODE 4140-01-P